Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

A. Cuneo, G. Follows, G.M. Rigolin, A. Piciocchi, A. Tedeschi, L. Trentin, A.M. Perez, M. Coscia, L. Laurenti, G. Musuraca, L. Farina, A.R. Delgado, E.M. Orlandi, P. Galieni, F.R. Mauro, C. Visco, A. Amendola, A. Billio, R. Marasca, A. ChiarenzaV. Meneghini, F. Ilariucci, M. Marchetti, S. Molica, F. Re, G. Gaidano, M. Gonzalez, F. Forconi, S. Ciolli, A. Cortelezzi, M. Montillo, L. Smolej, A. Schuh, T.A. Eyre, B. Kennedy, K.M. Bowles, M. Vignetti, J. De La Serna, C. Moreno, R. Foà, P. Ghia, GIMEMA Party, European Research Initiative on CLL (ERIC), UK CLL forum

Research output: Contribution to journal › Article

Original languageUndefined/Unknown
Pages (from-to)1209-1217
Number of pages9
JournalHaematologica
Volume103
Issue number7
DOIs
Publication statusPublished - 2018

Cite this

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study. / Cuneo, A.; Follows, G.; Rigolin, G.M.; Piciocchi, A.; Tedeschi, A.; Trentin, L.; Perez, A.M.; Coscia, M.; Laurenti, L.; Musuraca, G.; Farina, L.; Delgado, A.R.; Orlandi, E.M.; Galieni, P.; Mauro, F.R.; Visco, C.; Amendola, A.; Billio, A.; Marasca, R.; Chiarenza, A.; Meneghini, V.; Ilariucci, F.; Marchetti, M.; Molica, S.; Re, F.; Gaidano, G.; Gonzalez, M.; Forconi, F.; Ciolli, S.; Cortelezzi, A.; Montillo, M.; Smolej, L.; Schuh, A.; Eyre, T.A.; Kennedy, B.; Bowles, K.M.; Vignetti, M.; De La Serna, J.; Moreno, C.; Foà, R.; Ghia, P.; Party, GIMEMA; (ERIC), European Research Initiative on CLL; forum, UK CLL.

In: Haematologica, Vol. 103, No. 7, 2018, p. 1209-1217.

Research output: Contribution to journal › Article

Cuneo, A, Follows, G, Rigolin, GM, Piciocchi, A, Tedeschi, A, Trentin, L, Perez, AM, Coscia, M, Laurenti, L, Musuraca, G, Farina, L, Delgado, AR, Orlandi, EM, Galieni, P, Mauro, FR, Visco, C, Amendola, A, Billio, A, Marasca, R, Chiarenza, A, Meneghini, V, Ilariucci, F, Marchetti, M, Molica, S, Re, F, Gaidano, G, Gonzalez, M, Forconi, F, Ciolli, S, Cortelezzi, A, Montillo, M, Smolej, L, Schuh, A, Eyre, TA, Kennedy, B, Bowles, KM, Vignetti, M, De La Serna, J, Moreno, C, Foà, R, Ghia, P, Party, GIMEMA, (ERIC), ERIOCLL & forum, UKCLL 2018, 'Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study', Haematologica, vol. 103, no. 7, pp. 1209-1217. https://doi.org/10.3324/haematol.2018.189837
Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L et al. Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study. Haematologica. 2018;103(7):1209-1217. https://doi.org/10.3324/haematol.2018.189837
Cuneo, A. ; Follows, G. ; Rigolin, G.M. ; Piciocchi, A. ; Tedeschi, A. ; Trentin, L. ; Perez, A.M. ; Coscia, M. ; Laurenti, L. ; Musuraca, G. ; Farina, L. ; Delgado, A.R. ; Orlandi, E.M. ; Galieni, P. ; Mauro, F.R. ; Visco, C. ; Amendola, A. ; Billio, A. ; Marasca, R. ; Chiarenza, A. ; Meneghini, V. ; Ilariucci, F. ; Marchetti, M. ; Molica, S. ; Re, F. ; Gaidano, G. ; Gonzalez, M. ; Forconi, F. ; Ciolli, S. ; Cortelezzi, A. ; Montillo, M. ; Smolej, L. ; Schuh, A. ; Eyre, T.A. ; Kennedy, B. ; Bowles, K.M. ; Vignetti, M. ; De La Serna, J. ; Moreno, C. ; Foà, R. ; Ghia, P. ; Party, GIMEMA ; (ERIC), European Research Initiative on CLL ; forum, UK CLL. / Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study. In: Haematologica. 2018 ; Vol. 103, No. 7. pp. 1209-1217.
@article{129cc6aab56844deac00396c501f6038,
title = "Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study",
author = "A. Cuneo and G. Follows and G.M. Rigolin and A. Piciocchi and A. Tedeschi and L. Trentin and A.M. Perez and M. Coscia and L. Laurenti and G. Musuraca and L. Farina and A.R. Delgado and E.M. Orlandi and P. Galieni and F.R. Mauro and C. Visco and A. Amendola and A. Billio and R. Marasca and A. Chiarenza and V. Meneghini and F. Ilariucci and M. Marchetti and S. Molica and F. Re and G. Gaidano and M. Gonzalez and F. Forconi and S. Ciolli and A. Cortelezzi and M. Montillo and L. Smolej and A. Schuh and T.A. Eyre and B. Kennedy and K.M. Bowles and M. Vignetti and {De La Serna}, J. and C. Moreno and R. Fo{\`a} and P. Ghia and GIMEMA Party and (ERIC), {European Research Initiative on CLL} and forum, {UK CLL}",
note = "cited By 2",
year = "2018",
doi = "10.3324/haematol.2018.189837",
language = "Non definita",
volume = "103",
pages = "1209--1217",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "7",

}

TY - JOUR

T1 - Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

AU - Cuneo, A.

AU - Follows, G.

AU - Rigolin, G.M.

AU - Piciocchi, A.

AU - Tedeschi, A.

AU - Trentin, L.

AU - Perez, A.M.

AU - Coscia, M.

AU - Laurenti, L.

AU - Musuraca, G.

AU - Farina, L.

AU - Delgado, A.R.

AU - Orlandi, E.M.

AU - Galieni, P.

AU - Mauro, F.R.

AU - Visco, C.

AU - Amendola, A.

AU - Billio, A.

AU - Marasca, R.

AU - Chiarenza, A.

AU - Meneghini, V.

AU - Ilariucci, F.

AU - Marchetti, M.

AU - Molica, S.

AU - Re, F.

AU - Gaidano, G.

AU - Gonzalez, M.

AU - Forconi, F.

AU - Ciolli, S.

AU - Cortelezzi, A.

AU - Montillo, M.

AU - Smolej, L.

AU - Schuh, A.

AU - Eyre, T.A.

AU - Kennedy, B.

AU - Bowles, K.M.

AU - Vignetti, M.

AU - De La Serna, J.

AU - Moreno, C.

AU - Foà, R.

AU - Ghia, P.

AU - Party, GIMEMA

AU - (ERIC), European Research Initiative on CLL

AU - forum, UK CLL

N1 - cited By 2

PY - 2018

Y1 - 2018

U2 - 10.3324/haematol.2018.189837

DO - 10.3324/haematol.2018.189837

M3 - Articolo

VL - 103

SP - 1209

EP - 1217

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 7

ER -

Access to Document

Related content

Projects

ISTITUTO TUMORI MILANO - MEDICINA DI PRECISIONE E INNOVAZIONE TECNOLOGICA (FARMACOLOGICA E NON)

Project: Other project